OrbiMed $600M Royalty Fund Opens for Business
By Catherine Shaffer
Thursday, September 1, 2011
OrbiMed Advisors LLC has closed a new fund dedicated to acquiring health care royalty streams and providing minimally dilutive debt capital to companies in the health care sector. The $600 million fund will provide an alternative to financing through the equity markets for companies with approved products or products close to approval. The fund has already made two investments: XOMA Ltd. and Velico Medical Inc.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.